| |
| |
|
| Insider
Information: |
Kelly Paul Edward |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
187,295 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$717,340 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
187,295 |
|
|
| Total
Value |
$717,340 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Relmada Therapeutics, Inc. |
RLMD |
Director |
2022-04-04 |
187,295 |
2015-12-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2022-04-04 |
4 |
AS |
$30.04 |
$300,395 |
D/D |
(10,000) |
187,295 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2022-04-04 |
4 |
OE |
$3.24 |
$32,400 |
D/D |
10,000 |
197,295 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2022-01-03 |
4 |
OE |
$3.24 |
$64,800 |
D/D |
20,000 |
187,295 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2021-03-09 |
4 |
AS |
$35.42 |
$178,551 |
D/D |
(5,000) |
167,295 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2021-03-09 |
4 |
OE |
$3.24 |
$16,200 |
D/D |
5,000 |
172,295 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2021-02-24 |
4 |
AS |
$33.67 |
$170,933 |
D/D |
(5,000) |
167,295 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2021-02-24 |
4 |
OE |
$3.24 |
$16,200 |
D/D |
5,000 |
172,295 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2021-02-16 |
4 |
OE |
$6.00 |
$30,000 |
D/D |
5,000 |
167,295 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2021-02-09 |
4 |
AS |
$35.29 |
$73,005 |
D/D |
(2,069) |
162,295 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2021-02-08 |
4 |
AS |
$35.04 |
$52,560 |
D/D |
(1,500) |
164,364 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2021-02-08 |
4 |
OE |
$3.24 |
$11,564 |
D/D |
3,569 |
165,864 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2021-02-02 |
4 |
AS |
$35.04 |
$81,118 |
D/D |
(2,315) |
162,295 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2021-02-01 |
4 |
AS |
$35.00 |
$1,085 |
D/D |
(31) |
164,610 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2021-02-01 |
4 |
OE |
$3.24 |
$56,201 |
D/D |
17,346 |
164,641 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2021-01-27 |
4 |
AS |
$31.69 |
$162,323 |
D/D |
(5,000) |
147,295 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2021-01-27 |
4 |
OE |
$3.24 |
$16,200 |
D/D |
5,000 |
152,295 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2021-01-26 |
4 |
AS |
$35.16 |
$24,085 |
D/D |
(685) |
147,295 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2021-01-25 |
4 |
AS |
$35.27 |
$45,851 |
D/D |
(1,300) |
147,980 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2021-01-22 |
4/A |
AS |
$35.43 |
$63,774 |
D/D |
(1,800) |
149,580 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2021-01-22 |
4 |
AS |
$36.18 |
$6,388,254 |
D/D |
(2,100) |
149,280 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2021-01-22 |
4 |
OE |
$3.24 |
$13,235 |
D/D |
4,085 |
151,380 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2020-08-18 |
4 |
OE |
$3.24 |
$71,280 |
D/D |
22,000 |
149,121 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2020-08-18 |
4 |
D |
$39.03 |
$71,269 |
D/D |
(1,826) |
147,295 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2019-10-18 |
4 |
B |
$18.99 |
$95,685 |
D/D |
5,000 |
127,121 |
2.39 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2018-12-11 |
4 |
B |
$1.21 |
$6,065 |
D/D |
5,000 |
388,483 |
2.39 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
